In vivo visualization of metastatic prostate cancer and quantitation of disease progression in immunocompromised mice

Cancer Biology and Therapy

Volumn 2, Issue 6, 2003, Pages 656-660

  Kalikin, Linda M ^a   Schneider, Abraham ^b   Thakur, Melissa A ^a   Fridman, Yaron ^a   Griffin, Laura B ^c   Dunn, Rodney L ^a   Rosol, Thomas J ^d   Shah, Rajal B ^c   Rehemtulla, Alnawaz ^c   McCauley, Laurie K ^b,c   Pienta, Kenneth J ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

Bioluminescence; Growth kinetics; Luciferase; Metastasis; PC 3; Prostate cancer; Xenograft model

Indexed keywords

LUCIFERASE;

ANIMAL; ARTICLE; CELL DIVISION; CELL TRANSFORMATION; CELL TRANSPLANTATION; DIAGNOSTIC IMAGING; DISEASE COURSE; GENETICS; HUMAN; KINETICS; LUMINESCENCE; MALE; METABOLISM; METASTASIS; MOUSE; MOUSE MUTANT; OSTEOCLAST; PATHOLOGY; PATHOPHYSIOLOGY; PROSTATE TUMOR; RETROVIRUS; SPINE; TUMOR CELL LINE; VIRUS CELL TRANSFORMATION;

ANIMALS; CELL DIVISION; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; CELL TRANSPLANTATION; DIAGNOSTIC IMAGING; DISEASE PROGRESSION; HUMANS; KINETICS; LUCIFERASES; LUMINESCENT MEASUREMENTS; MALE; MICE; MICE, SCID; NEOPLASM METASTASIS; OSTEOCLASTS; PROSTATIC NEOPLASMS; RETROVIRIDAE; SPINE;

EID: 79960785065     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.2.6.531     Document Type: Article

References (24)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003; 53:5-26.
2. Hankey BF, Feuer EJ, Clegg LX, Hayes RB, Legler JM, Prorok PC, et al. Cancer surveillance series: Interpreting trends in prostate cancer - part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst 1999; 91:1017-24. (Pubitemid 29293040)
3. Carroll P. Rising PSA after a radical treatment. Eur Urol 2001; 40 Suppl 2:9-16. (Pubitemid 34701912)
4. Pilat MJ, Kamradt JM, Pienta KJ. Hormone resistance in prostate cancer. Cancer Metastasis Rev 1998; 17:373-81.
5. Gingrich JR, Barrios RJ, Morton RA, Boyce BF, DeMayo FJ, Finegold MJ, et al. Metastatic prostate cancer in a transgenic mouse. Cancer Res 1996; 56:4096-102. (Pubitemid 26304996)
6. An Z, Wang X, Geller J, Moossa AR, Hoffman RM. Surgical orthotopic implantation allows high lung and lymph node metastatic expression of human prostate carcinoma cell line PC-3 in nude mice. Prostate 1998; 34:169-74.
7. Rubin MA, Putzi M, Mucci N, Smith DC, Wojno K, Korenchuk S, et al. Rapid ("warm") autopsy study for procurement of metastatic prostate cancer. Clin Cancer Res 2000; 6:1038-45. (Pubitemid 30159365)
8. Rosol TJ, Tannehill-Gregg SH, LeRoy BE, Mandl S, Contag CH. Animal models of bone metastasis. Cancer 2003; 97(3 Suppl):748-57.
9. Edinger M, Cao YA, Hornig YS, Jenkins DE, Verneris MR, Bachmann MH, et al. Advancing animal models of neoplasia through in vivo bioluminescence imaging. Eur J Cancer 2002; 38:2128-36. (Pubitemid 35223250)
10. Timmins GS, Robb FJ, Wilmot CM, Jackson SK, Swartz HM. Firefly flashing is controlled by gating oxygen to light-emitting cells. J Exp Biol 2001; 204:2795-801. (Pubitemid 34861389)
11. Rice BW, Cable MD, Nelson MB. In vivo imaging of light-emitting probes. J Biomed Opt 2001; 6:432-40.
12. Rehemtulla A, Stegman LD, Cardozo SJ, Gupta S, Hall DE, Contag CH, et al. Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2000; 2:491-5. (Pubitemid 32098683)
13. Rubio N, Villacampa MM, El Hilali N, Blanco J. Metastatic burden in nude mice organs measured using prostate tumor PC-3 cells expressing the luciferase gene as a quantifiable tumor cell marker. Prostate 2000; 44:133-43. (Pubitemid 30419188)
14. Nyati MK, Symon Z, Kievit E, Dornfeld KJ, Rynkiewicz SD, Ross BD, et al. The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer model. Gene Ther 2002; 9:844-9. (Pubitemid 34716328)
15. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002; 2:563-72.
16. Bianco FJ, Jr., Wood DP, Jr., Gomes de Oliveira J, Nemeth JA, Beaman AA, Cher ML. Proliferation of prostate cancer cells in the bone marrow predicts recurrence in patients with localized prostate cancer. Prostate 2001; 49:235-42. (Pubitemid 33116998)
17. Bubendorf L, Schopfer A, Wagner U, Sauter G, Moch H, Willi N, et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol 2000; 31:578-83. (Pubitemid 30323983)
18. Tiffee JC, Xing L, Nilsson S, Boyce BF. Dental abnormalities associated with failure of tooth eruption in src knockout and op/op mice. Calcif Tissue Int 1999; 65:53-8. (Pubitemid 29293528)
19. Ebling FJ, Ebling E, Randall V, Skinner J. The synergistic action of alpha-melanocyte-stimulating hormone and testosterone of the sebaceous, prostate, preputial, Harderian and lachrymal glands, seminal vesicles and brown adipose tissue in the hypophysectomized-castrated rat. J Endocrinol 1975; 66:407-12.
20. Miyaura C, Toda K, Inada M, Ohshiba T, Matsumoto C, Okada T, et al. Sex- and age-related response to aromatase deficiency in bone. Biochem Biophys Res Commun 2001; 280:1062-8. (Pubitemid 32924448)
21. Maeda H, Segawa T, Kamoto T, Yoshida H, Kakizuka A, Ogawa O, et al. Rapid detection of candidate metastatic foci in the orthotopic inoculation model of androgen-sensitive prostate cancer cells introduced with green fluorescent protein. Prostate 2000; 45:335-40.
22. Vooijs M, Jonkers J, Lyons S, Berns A. Noninvasive imaging of spontaneous retinoblastoma pathway-dependent tumors in mice. Cancer Res 2002; 62:1862-7. (Pubitemid 34408514)
23. El Hilali N, Rubio N, Martinez-Villacampa M, Blanco J. Combined noninvasive imaging and luminometric quantification of luciferase-labeled human prostate tumors and metastases. Lab Invest 2002; 82:1563-71. (Pubitemid 35332915)
24. Zhang J, Dai J, Qi Y, Lin DL, Smith P, Strayhorn C, et al. Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone. J Clin Invest 2001; 107:1235-44. (Pubitemid 32494540)